Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nargund

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|July 1, 2004
Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRbA W Hitchings, M Kumar, S Jordan, et al.
The American Journal of Pathology|September 1, 1996
Progressive loss of CD44 gene expression in invasive bladder cancerT Sugino, H Gorham, K Yoshida, et al.
Urologia Internationalis|December 13, 2001
Phase 1/2 study of synchronous methotrexate, cisplatin, vincristine (MOPq10) chemotherapy and radiation for patients with locally advanced bladder cancerT I Goonewardene, H Bozcuk, R T Oliver, et al.
Cancer|January 15, 1997
Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urineK Yoshida, T Sugino, H Tahara, et al.
British Journal of Cancer|September 18, 2008
Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort studyC Metcalfe, S Evans, F Ibrahim, et al.
British Journal of Cancer|November 26, 2009
Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort studyS Evans, C Metcalfe, B Patel, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|July 1, 2004
Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRbA W Hitchings, M Kumar, S Jordan, et al.
The American Journal of Pathology|September 1, 1996
Progressive loss of CD44 gene expression in invasive bladder cancerT Sugino, H Gorham, K Yoshida, et al.
Urologia Internationalis|December 13, 2001
Phase 1/2 study of synchronous methotrexate, cisplatin, vincristine (MOPq10) chemotherapy and radiation for patients with locally advanced bladder cancerT I Goonewardene, H Bozcuk, R T Oliver, et al.
Cancer|January 15, 1997
Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urineK Yoshida, T Sugino, H Tahara, et al.
British Journal of Cancer|September 18, 2008
Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort studyC Metcalfe, S Evans, F Ibrahim, et al.
British Journal of Cancer|November 26, 2009
Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort studyS Evans, C Metcalfe, B Patel, et al.
Pageof 2